Advertisement
Australia markets close in 2 hours 3 minutes
  • ALL ORDS

    7,848.90
    -88.60 (-1.12%)
     
  • ASX 200

    7,587.50
    -95.50 (-1.24%)
     
  • AUD/USD

    0.6524
    +0.0000 (+0.01%)
     
  • OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD

    2,346.70
    +4.20 (+0.18%)
     
  • Bitcoin AUD

    98,660.19
    +262.92 (+0.27%)
     
  • CMC Crypto 200

    1,390.52
    +7.94 (+0.57%)
     
  • AUD/EUR

    0.6082
    +0.0009 (+0.15%)
     
  • AUD/NZD

    1.0951
    -0.0006 (-0.06%)
     
  • NZX 50

    11,824.23
    -122.20 (-1.02%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,612.17
    +327.63 (+1.90%)
     
  • NIKKEI 225

    37,903.05
    +274.57 (+0.73%)
     

SmileDirectClub Sets Record: Worst First Day for a Big IPO Since at Least 2000

Shares of SmileDirectClub, Inc. Fell 28% on Their First Day of Trade

By John Jannarone

This is one record that’s nothing to smile about.

Shares of SmileDirectClub, Inc., the much-hyped orthodontics disruptor, fell 28% Thursday after pricing at $23 each, above the indicative range of $19 and $22 per share.

That is by far the worst first-day performance for an IPO selling $500 million in shares or more since at least 2000, according to Dealogic. In a distant second place was Moderna, which fell 19% on its first day of trade last December. Among the other stinkers on the list is Uber Technologies, Inc., which fell 8% on its first day of trade in May.

SmileDirectClub, which sells teeth aligners by mail that don’t require orthodontists visits and are far less expensive than traditional braces, has been a battleground stock even before listing. One firm that was highly skeptical of the deal was Renaissance Capital.

ADVERTISEMENT

“[B]ecause the clear aligners are not differentiated in any substantial way, the company has had to increase spending on sales and marketing to stay ahead of a growing pool of competitors, making the path to profitability unclear,” Renaissance Capital wrote in a client note dated September 5. “Although the management team has experience running direct-to-consumer businesses, this deal is structured to enrich the founding family and insiders and leave control in their hands, and the proposed valuation does not give new investors anything to smile about.”

JPMorgan Chase & Co. and Citigroup, Inc. were the lead managers on the deal.

Contact:

John Jannarone, Editor-in-Chief

editor@IPO-Edge.com

www.IPO-Edge.com

Editor@IPO-Edge.com

Twitter: @IPOEdge

Instagram: @IPOEdge